Cell penetrating peptide conjugates and methods of use thereof

Disclosed are conjugates of an oligonucleotide and a peptide covalently bonded to the oligonucleotide or linked by a linker, the peptide comprising at least one cationic domain comprising at least 4 amino acid residues and at least one hydrophobic domain comprising at least 3 amino acid residues, with the proviso that the peptide comprises 7 to 40 amino acid residues in total and does not comprise any artificial amino acid residues; the oligonucleotide comprises a total of 12 to 40 contiguous nucleobases, wherein at least 12 contiguous nucleobases are complementary to a target sequence in the human dystrophin gene..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 26. Dez. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

WOOD MATTHEW [VerfasserIn]
MANZANO RAQUEL [VerfasserIn]
GODFREY CAROLINE [VerfasserIn]
MCCLORY GRAHAM [VerfasserIn]
RAZ RICHARD [VerfasserIn]
GUETTER MICHAEL [VerfasserIn]
ARZUMANOV ANDREY [VerfasserIn]
O 'DONOVAN LIZ [VerfasserIn]
HAZELL GARETH [VerfasserIn]
HOLLAND ASHLYN [VerfasserIn]
VARELA MIGUEL [VerfasserIn]
BANERJEE SUHAS [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-12-26, Last update posted on www.tib.eu: 2024-04-22, Last updated: 2024-04-26

Patentnummer:

CN117295525

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA000100730